HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 02/21/2013 -- Meru Networks, Inc. (NASDAQ:MERU) skyrocketed 19.88% after news that three of its current board members had assumed new leadership positions on the company’s board of directors and its committees. Harold Copperman has been named Lead Director, Chuck Kissner named Chairman of the Nominating and Governance Committee and Barry Newman named Chairman of the Audit Committee.
How Should Investors Trade MERU After The Recent Fall? Find Out Here
Novogen Limited (ADR) (NASDAQ:NVGN) soared 25.97% after upbeat results for its lead experimental drug, CS-6, against ovarian cancer stem cells. In laboratory studies, CS-6 demonstrated strong anti-cancer activity against cancer cells representative of a wide range of malignancies such as ovarian cancer and glioma (brain) cancer, but notable thing was to extend this to see whether the drug also performed well against cancer stem cells.
What Are NVGN’s Charts Signaling For Traders? Find Out Here
Endeavour International Co. (NYSE:END) opened at 3.34. Endeavour International Co. has a 52 week low of $2.95 and a 52 week high of $13.48. The stock’s 50-day moving average is currently $5.23. The company’s market cap is $153.1 million. The company’s relative strength index is at 24.60 which shows that the stock is oversold.
Is END a Solid Investment at These Levels? Find Out Here
La-Z-Boy Incorporated (NYSE:LZB) gapped up sharply Wednesday, but traded in a range for the majority of the session. The stock closed higher by 1.77 at $17.23, with volume at an 8-month high. La-Z-Boy rose past resistance and set a new high for the year. Company reported third quarter net income of $0.32 per share after the bell Tuesday, compared to $0.28 per share last year. The consensus estimate was for EPS of $0.23.
How Should Investors Trade LZB After The Recent Volatile Moves? Find Out Here
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) jumped 10.99% after Piper Jaffray upgraded the stock to overweight rating and lifted the price target to $10, citing its TH-302 opportunity.
Will New Regulations Weigh over THLD Revenue Stream? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)